| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0735-1097(00)00952-9 |
| P698 | PubMed publication ID | 11092646 |
| P50 | author | Richard O. Cannon | Q124352151 |
| P2093 | author name string | L M Wahl | |
| G Csako | |||
| B K Yang | |||
| M A Waclawiw | |||
| D Zanger | |||
| J Ardans | |||
| P2860 | cites work | Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis | Q77544912 |
| Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques | Q77756578 | ||
| Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women | Q77905025 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| Matrix metalloproteinases: a review | Q29620220 | ||
| Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites | Q29620551 | ||
| 17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells | Q32065039 | ||
| Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women | Q34067367 | ||
| Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 | ||
| Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion | Q35208646 | ||
| Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi | Q36745409 | ||
| 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region | Q36842600 | ||
| Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex | Q38337741 | ||
| Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina | Q39817564 | ||
| Matrix metalloproteinases and cardiovascular disease | Q40410789 | ||
| Molecular bases of the acute coronary syndromes | Q40530238 | ||
| Hormone replacement therapy and increased plasma concentration of C-reactive protein | Q40801238 | ||
| C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction | Q40857092 | ||
| Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. | Q40872170 | ||
| Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study | Q40873641 | ||
| The AP-1 site and MMP gene regulation: what is all the fuss about? | Q41460650 | ||
| Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study | Q43776201 | ||
| Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study | Q43788768 | ||
| Cultured rat aortic vascular smooth muscle cells digest naturally produced extracellular matrix. Involvement of plasminogen-dependent and plasminogen-independent pathways | Q44663539 | ||
| Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina | Q46149107 | ||
| Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes | Q47671940 | ||
| Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease | Q47974127 | ||
| Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. | Q50950290 | ||
| Elevated Levels of Interleukin-6 in Unstable Angina | Q58230354 | ||
| Role of plasminogen activator in degradation of extracellular matrix protein by live human alveolar macrophages | Q68264629 | ||
| Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death | Q69587081 | ||
| Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content | Q71102869 | ||
| Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease | Q71244128 | ||
| Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial | Q71512983 | ||
| The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis | Q71605264 | ||
| Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women | Q73090822 | ||
| The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women | Q73914741 | ||
| Hormone replacement therapy, inflammation, and hemostasis in elderly women | Q77297626 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | coronary artery disease | Q844935 |
| P304 | page(s) | 1797-1802 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management | |
| P478 | volume | 36 |
| Q35581561 | Adhesion molecules and atherosclerosis |
| Q44562478 | Association between Gly241Arg ICAM-1 gene polymorphism and serum sICAM-1 concentration in the Stanislas cohort |
| Q42487474 | Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women |
| Q34007712 | Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormones in postmenopausal women. |
| Q54972686 | Cardiovascular consequences of hormone therapy in postmenopausal women: Messages to clinicians. |
| Q35544330 | Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction |
| Q36568449 | Clinical opinion: the biologic and pharmacologic principles for age-adjusted long-term estrogen therapy |
| Q44439753 | Effect of Short-Term estrogen with and without progesterone therapy on circulating markers of endothelial activation and injury in postmenopausal women with unstable angina pectoris |
| Q44044419 | Effect of hormone replacement therapy on carotid arterial compliance in healthy postmenopausal women |
| Q37563372 | Effect of hormone replacement therapy on inflammatory biomarkers. |
| Q37145839 | Effects of estrogen versus estrogen and progesterone on cortisol and interleukin-6 |
| Q34727136 | Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation |
| Q40632178 | Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women |
| Q43852478 | Estrogen therapy for unstable angina: another bump for the bandwagon |
| Q34532001 | Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction--a nationwide cohort study |
| Q34327242 | Hormone replacement therapy for prevention of coronary heart disease: current evidence |
| Q51808544 | Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response |
| Q37417429 | Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal women |
| Q81002469 | Is the WHI relevant to HRT started in the perimenopause? |
| Q44642214 | Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS). |
| Q44770881 | Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? |
| Q37276377 | Pathogenesis of atherosclerosis: A multifactorial process. |
| Q53568806 | Plasma matrix metalloproteinase 2 levels and breast cancer risk. |
| Q34482151 | Postmenopausal hormone replacement therapy as antiatherosclerotic therapy |
| Q79754070 | The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results |
| Q35617189 | The role of estrogen in cardiovascular disease |
| Q24816543 | The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-kappa B transcriptional activity in models of rheumatoid arthritis |
| Q37975897 | Vascular effects of glycoprotein130 ligands--part II: biomarkers and therapeutic targets |
Search more.